Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Vertex Pharmaceuticals Inc Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

  • $94.9 Billion
  • Q3 2024

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 1,037,248 shares of VRTX stock, worth $468 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,037,248
Previous 1,091,299 4.95%
Holding current value
$468 Million
Previous $512 Million 5.69%
% of portfolio
0.51%
Previous 0.56%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $24.9 Million - $27.3 Million
-54,051 Reduced 4.95%
1,037,248 $482 Million
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $311 Million - $384 Million
791,828 Added 264.41%
1,091,299 $512 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $3.57 Million - $3.91 Million
8,756 Added 3.01%
299,471 $125 Million
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $25.8 Million - $30.9 Million
75,345 Added 34.98%
290,715 $118 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $13.1 Million - $14 Million
38,677 Added 21.89%
215,370 $74.9 Million
Q2 2023

May 17, 2024
SELL
$314.42 - $351.91 $38.6 Million - $43.2 Million
-122,778 Reduced 41.0%
176,693 $62.2 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $6.93 Million - $7.76 Million
22,039 Added 14.25%
176,693 $62.2 Million
Q1 2023

May 17, 2024
SELL
$283.23 - $323.1 $4.91 Million - $5.6 Million
-17,346 Reduced 10.08%
154,654 $48.7 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $4.91 Million - $5.6 Million
-17,346 Reduced 10.08%
154,654 $48.7 Million
Q4 2022

May 17, 2024
SELL
$285.76 - $321.48 $36.4 Million - $41 Million
-127,471 Reduced 42.57%
172,000 $49.7 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $1.62 Million - $1.82 Million
-5,674 Reduced 3.19%
172,000 $49.7 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $8.08 Million - $9.02 Million
-29,522 Reduced 14.25%
177,674 $51.4 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $3.78 Million - $4.71 Million
-16,096 Reduced 7.21%
207,196 $58.4 Million
Q1 2022

May 16, 2022
BUY
$221.42 - $260.97 $4.32 Million - $5.09 Million
19,506 Added 9.57%
223,292 $58.3 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $5.04 Million - $6.37 Million
-28,486 Reduced 12.26%
203,786 $45.3 Million
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $10.4 Million - $11.6 Million
-57,087 Reduced 19.73%
232,272 $42.1 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $9.76 Million - $11.5 Million
-52,074 Reduced 15.25%
289,359 $58.3 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $81 Million - $94.4 Million
-391,304 Reduced 53.4%
341,433 $73.4 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $277 Million - $369 Million
-1,337,697 Reduced 64.61%
732,737 $171 Million
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $66.4 Million - $78.7 Million
259,727 Added 14.34%
2,070,434 $563 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $34.4 Million - $45.1 Million
152,347 Added 9.19%
1,810,707 $526 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $4.4 Million - $5.45 Million
22,008 Added 1.34%
1,658,360 $395 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $21.9 Million - $29.5 Million
131,528 Added 8.74%
1,636,352 $358 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $17 Million - $19.1 Million
102,011 Added 7.27%
1,504,824 $255 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $228 Million - $264 Million
1,385,145 Added 7839.85%
1,402,813 $257 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $53,539 - $63,666
327 Added 1.89%
17,668 $3.25 Million
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $266,905 - $337,712
1,757 Added 11.27%
17,341 $2.8 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $2.52 Million - $2.89 Million
15,000 Added 2568.49%
15,584 $0
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $1.02 Million - $1.19 Million
-7,000 Reduced 92.3%
584 $99,000
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $1.06 Million - $1.24 Million
7,000 Added 1198.63%
7,584 $1.24 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $80,171 - $90,841
584
584 $87,000

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email